Verrica Pharmaceuticals Inc.
Hedge Funds Holdings
Last updated:
Verrica Pharmaceuticals Inc.‘s stocks are currently a part of 46 hedge funds’ portfolios, which represents 32.84% of the total amount of its stocks outstanding. This makes up a total of 8.88M shares of Verrica Pharmaceuticals Inc.. Compared to the previous quarter, the number fell by -0.79% or -71.08K shares fewer. As for the holding position changes, 19.57% (9) of current hedge fund investors increased the number of shares held, 39.13% (18) of current holders sold a part of the shares held, and 10.87% (5) closed the holdings completely. 7 hedge funds are new holders of Verrica Pharmaceuticals Inc. stock in Q1 2022, it is 15.22% of total holders.
Hedge funds holding Verrica Pharmaceuticals (Q2 2018 – Q1 2022)
| Q2 2018 | 28 |
|---|---|
| Q3 2018 | 45 |
| Q4 2018 | 41 |
| Q1 2019 | 40 |
| Q2 2019 | 41 |
| Q3 2019 | 42 |
| Q4 2019 | 52 |
| Q1 2020 | 48 |
| Q2 2020 | 48 |
| Q3 2020 | 47 |
| Q4 2020 | 44 |
| Q1 2021 | 51 |
| Q2 2021 | 53 |
| Q3 2021 | 49 |
| Q4 2021 | 44 |
| Q1 2022 | 46 |
Hedge funds changes in Verrica Pharmaceuticals positions (Q2 2018 – Q1 2022)
| Q2 2018 | 28 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 24 | 9 | 7 | 7 | -2 |
| Q4 2018 | 5 | 19 | 8 | 8 | 1 |
| Q1 2019 | 4 | 19 | 5 | 4 | 8 |
| Q2 2019 | 4 | 19 | 6 | 3 | 9 |
| Q3 2019 | 5 | 17 | 9 | 4 | 7 |
| Q4 2019 | 13 | 21 | 7 | 3 | 8 |
| Q1 2020 | 4 | 15 | 17 | 7 | 5 |
| Q2 2020 | 6 | 15 | 14 | 6 | 7 |
| Q3 2020 | 4 | 8 | 23 | 5 | 7 |
| Q4 2020 | 3 | 16 | 12 | 6 | 7 |
| Q1 2021 | 9 | 14 | 19 | 2 | 7 |
| Q2 2021 | 11 | 11 | 18 | 9 | 4 |
| Q3 2021 | 5 | 17 | 12 | 9 | 6 |
| Q4 2021 | 4 | 18 | 11 | 10 | 1 |
| Q1 2022 | 7 | 9 | 18 | 5 | 7 |
Hedge funds changes in Verrica Pharmaceuticals stock options (Q2 2018 – Q1 2022)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 3,000 | 2,000 |
| Q3 2021 | 329,000 | 502,000 |
| Q4 2021 | 49,000 | 3,000 |
| Q1 2022 | 0 | 0 |